Has Deborah Hatch received payments from drug or device companies?

Yes. Drug and device makers reported $2,405 in general payments to Deborah Hatch across 108 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Deborah Hatch did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Deborah Hatch come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Deborah Hatch

Physician Assistant · Salt Lake City, UTNPI 1346644135

Payments from drug & device makers

$2,405in general payments, 2019–2025

Across 108 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$214
AstraZeneca$187
Pfizer$156
Daiichi Sankyo Inc.$130
Takeda Pharmaceuticals U.S.A., Inc.$119
Bristol Myers Squibb$109
plus $1K from 36 others

What the payments were for

Food & beverage$2,06086%
Education$34514%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	7	$214
AstraZeneca	10	$187
Pfizer	8	$156
Daiichi Sankyo Inc.	5	$130
Takeda Pharmaceuticals U.S.A., Inc.	6	$119
Bristol Myers Squibb	6	$109
EMD Serono, Inc.	5	$100
Incyte Corporation	1	$100
Astellas Pharma US Inc	3	$96
Seagen Inc.	2	$94
Novartis	4	$78
Merck	4	$75
Tersera Therapeutics LLC	3	$67
Lilly USA, LLC	4	$66
Sanofi	3	$62
Genentech USA, Inc.	2	$60
Deciphera Pharmaceuticals Inc.	3	$58
GSK	3	$54
Gilead(2 entities)	2	$48
Karyopharm Therapeutics Inc.	3	$46
Eisai Inc.	2	$43
E.r. Squibb & Sons, L.L.C.	2	$39
AMAG Pharmaceuticals, Inc.	1	$31
Genmab U.S., Inc.	1	$29
Recordati_rare_diseases_inc.	1	$26
Sumitomo Pharma America, Inc.	1	$25
Boehringer Ingelheim	1	$23
Rigel Pharmaceuticals, Inc.	1	$21
Array Biopharma Inc	1	$21
Pharmaessentia USA Corporation	1	$21
Cochlear Americas	1	$20
Pharmacyclics LLC, An Abbvie Company	1	$20
AbbVie	1	$19
Pharmacosmos Therapeutics Inc.	1	$19
Puma Biotechnology, Inc.	1	$19
Jazz Pharmaceuticals Inc.	1	$18
Sobi, Inc	1	$17
G1 Therapeutics, Inc.	1	$17
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$16
Agios Pharmaceuticals, Inc.	1	$15
Clovis Oncology, Inc.	1	$14
Beone Medicines USA, Inc.	1	$14

How this compares

$2,405 in reported general payments places this provider in the 85th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prochlorperazine Maleate	12	$204

Paid to pharmacies, not to this prescriber.

Other physician assistant in Salt Lake City

Jill EricksonSalt Lake City$179K
Natalie BeeSalt Lake City$63K
Samuel ShewanSalt Lake City$22K
Christy MaSalt Lake City$17K
Shane FarrSalt Lake City$14K
Gintare DaileySalt Lake City$13K
Corey DahlSalt Lake City$13K
David JonesSalt Lake City$12K
Corbin WoodSalt Lake City$12K
Amy HillierSalt Lake City$11K

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →